Otium Capital-backed Enosium completed the acquisition of Rweality.

Otium Capital-backed Enosium, a group specializing in life sciences, completed the acquisition of Rweality, a consulting and service firm. Financial terms were not disclosed. "I am very pleased to welcome Sandrine Bourguignon, a recognized leader and expert in the public health and health economics ecosystem, and the entire Rweality team to our group. This combination aligns perfectly with our development strategy and will accelerate our growth and leadership in market access services in France and Europe," Antoine Amer, Enosium Life Science Founder and CEO.